Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases. - Wikidata - awgldk - TriplyDB

Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases.

Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases.

http://www.wikidata.org/entity/Q34243421

about

Burden of illness of bone metastases in prostate cancer patients in Québec, Canada: A population-based analysis.Relationship Between Quality of Comorbid Condition Care and Costs for Cancer Survivors.Treatments for Metastatic Prostate Cancer (mPC): A Review of Costing Evidence.Role of mpMRI of the prostate in screening for prostate cancer.Racial variation in the clinical and economic burden of skeletal-related events among elderly men with stage IV metastatic prostate cancer.The Use of Corticosteroids as Adjuvant Therapy for Painful Bone Metastases: A Large Cross-Sectional Survey of Palliative Care Providers.

P2860

Q36326079-B1A4A110-7E07-45F9-9ED1-764304732719 Q37117877-9C41C487-C6DF-4677-9F58-FA6CBAD9A8F8 Q38653262-09760EE9-D230-447A-BB9F-09B4E59BD61B Q38671170-564D58F7-B7FA-4B66-8957-9EA1D9067E63 Q41147765-17A3DC6C-6BB6-48B7-B3AE-2DDD286F7C9C Q50897257-A2A33D8C-2224-4C2F-AA88-FB88E9C92E80

P2860

Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases.

http://www.wikidata.org/entity/Q34243421

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Comparing hospital-based resou ...... h and without bone metastases.

@ast

Comparing hospital-based resou ...... h and without bone metastases.

@en

Comparing hospital-based resou ...... h and without bone metastases.

@nl

type

label

Comparing hospital-based resou ...... h and without bone metastases.

@ast

Comparing hospital-based resou ...... h and without bone metastases.

@en

Comparing hospital-based resou ...... h and without bone metastases.

@nl

prefLabel

Comparing hospital-based resou ...... h and without bone metastases.

@ast

Comparing hospital-based resou ...... h and without bone metastases.

@en

Comparing hospital-based resou ...... h and without bone metastases.

@nl

P1433

Q34243421-3A0167CF-470A-4838-A111-3FF89093FA8A

P1476

Q34243421-D6197AD4-6A22-4A18-BF86-810973C7928C

P2093

Q34243421-0A800743-9F0A-485B-86D6-C05880838D87

Q34243421-10A648C3-2D6A-4058-A85D-E0B71C2EF105

Q34243421-25233F1B-55B1-4CB0-A959-3D6E6EB7E8D9

Q34243421-2DCA4CDF-83F6-4057-91B2-57A530D43FE1

Q34243421-385B575B-7279-4ACA-B9C7-7179136CAF57

Q34243421-96457824-06D2-45FF-BC4B-50A186A65872

Q34243421-CFEC8241-24FD-44C1-BD78-5408130A33EE

Q34243421-D79783A6-7334-4357-BC78-F8473F419816

Q34243421-FC46BCC9-6142-4630-B2AD-853ED5C4BF90

P2860

Q34243421-1157E9E2-4BF1-4DA2-BA25-AA7C9E27D35D

Q34243421-26C00978-848A-434B-B88D-384FBF2F5C26

Q34243421-2A04ADCB-CC25-4412-9187-D25402AB44B6

Q34243421-2CD7102D-9B39-4536-AD08-2162672E1518

Q34243421-48E92AAE-4120-4462-8893-6C67D65C1A55

Q34243421-59CD0506-E8BC-4B8F-A4F0-6F0BFAEE33AE

Q34243421-750FC9B6-60C6-4545-A01C-75AC015368FE

Q34243421-84511D22-E6E6-4CEF-A3A0-0A09A42BF632

Q34243421-879B0087-13D1-4266-99B8-258A09881705

Q34243421-8BB8278A-871C-461A-9A6A-5A92C6133DE2

P2888

Q34243421-BE4B78A1-AFE7-4EB9-B005-78EC6E0A085F

P304

Q34243421-3408AEF3-F227-41B8-90BF-5D2E6924A2AB

P31

Q34243421-F4993C07-8E56-4874-85EB-C8396289E895

P356

Q34243421-3A654612-0FFF-4F72-AF84-651195FE93EC

P433

Q34243421-75A5AB0C-71D5-4190-95D4-7064D72623E9

P478

Q34243421-75367F35-9CA4-40C9-9B7D-FC6429DCC731

P577

Q34243421-29B1B847-004B-4FEA-BC87-A27BC89D54C2

P5875

Q34243421-3730E7CC-39A2-44D7-8CEA-2C1947638A5C

P6179

Q34243421-A99EE1B9-53D8-4096-9599-34DFADA389E2

P698

Q34243421-328F543A-0CF6-4FE4-80BF-9162EE4261D9

P932

Q34243421-CF54BEA7-39EB-4195-8348-F3D152316ABB

P356

S40258-014-0101-1

P1433

Applied Health Economics and Health Policy

P1476

Comparing hospital-based resou ...... h and without bone metastases.

@en

P2093

Brian Seal

http://www.w3.org/2001/XMLSchema#string

Carl V Asche

http://www.w3.org/2001/XMLSchema#string

Eileen Farrelly

http://www.w3.org/2001/XMLSchema#string

Erin A Zagadailov

http://www.w3.org/2001/XMLSchema#string

Ken Shermock

http://www.w3.org/2001/XMLSchema#string

Michael Eaddy

http://www.w3.org/2001/XMLSchema#string

Scott D Ramsey

http://www.w3.org/2001/XMLSchema#string

Sean D Sullivan

http://www.w3.org/2001/XMLSchema#string

Syam Sarma

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Increased survival with enzalutamide in prostate cancer after chemotherapy

Abiraterone and increased survival in metastatic prostate cancer

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.

Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases.

Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.

Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study.

P2888

s40258-014-0101-1

P304

547-557

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40258-014-0101-1

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263816498

http://www.w3.org/2001/XMLSchema#string

P6179

1010547323

http://www.w3.org/2001/XMLSchema#string

P698

25005491

http://www.w3.org/2001/XMLSchema#string

P932

4175039

http://www.w3.org/2001/XMLSchema#string